Eton Pharmaceuticals, Inc. ETON Increase Decrease In Accrued Medicaid Rebates
Increase Decrease In Accrued Medicaid Rebates at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept eton:IncreaseDecreaseInAccruedMedicaidRebates.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s increase decrease in accrued medicaid rebates.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s increase decrease in accrued medicaid rebates?
- Eton Pharmaceuticals, Inc. (ETON) reported increase decrease in accrued medicaid rebates of $1.82M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s increase decrease in accrued medicaid rebates changed year-over-year?
- Eton Pharmaceuticals, Inc.'s increase decrease in accrued medicaid rebates decreased by 70.0% year-over-year, from $6.07M to $1.82M.
- What does increase decrease in accrued medicaid rebates mean?
- Tracks the change in liabilities related to estimated rebates owed to government programs for pharmaceutical products sold. Because these rebates are contingent on product utilization and government reporting, fluctuations reflect changes in sales volume and pricing strategies within the public sector. This metric is vital for understanding revenue recognition accuracy and potential cash outflows related to regulatory obligations.